0001104659-21-008998.txt : 20210128
0001104659-21-008998.hdr.sgml : 20210128
20210128215700
ACCESSION NUMBER: 0001104659-21-008998
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210126
FILED AS OF DATE: 20210128
DATE AS OF CHANGE: 20210128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Granfield Christine
CENTRAL INDEX KEY: 0001822190
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37990
FILM NUMBER: 21567839
MAIL ADDRESS:
STREET 1: C/O LEAP THERAPEUTICS
STREET 2: 47 THORNDIKE STREET, SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEAP THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001509745
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274412575
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 252 4343
MAIL ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Dekkun Corp
DATE OF NAME CHANGE: 20110107
4
1
tm214605-6_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-01-26
0
0001509745
LEAP THERAPEUTICS, INC.
LPTX
0001822190
Granfield Christine
C/O LEAP THERAPEUTICS, INC.
47 THORNDIKE STREET, SUITE B1-1
CAMBRIDGE
MA
02141
0
1
0
0
VP, Head of Reg Affairs/Qual
Employee Stock Option (Right to Buy)
2.57
2021-01-26
4
A
0
50000
0
A
2031-01-25
Common Stock
50000
50000
D
The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 36 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one month anniversary of January 26, 2021, the Vesting Start Date.
/s/ Douglas E. Onsi, as attorney-in-fact for Christine Granfield
2021-01-28